COM:CARATHERAPEUTICS
Cara Therapeutics
- Stock
Last Close
0.31
22/11 21:00
Market Cap
15.64M
Beta: -
Volume Today
508.47K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 17K - | 17K 0% | -408K - | -1.16M 184.68% | 538.50K 146.36% | 2.48M 361.19% | 2.60M 4.77% | |||||
average payables | 574K - | 595.50K 3.75% | 1.24M 108.23% | 3.35M 170.28% | 4.28M 27.81% | 4.10M 4.28% | 6.74M 64.28% | 7.00M 3.87% | 5.26M 24.83% | 7.61M 44.79% | 17.60M 131.11% | |
average receivables | 46K - | 130.50K 183.70% | 332K 154.41% | 701.50K 111.30% | 896.50K 27.80% | 1.22M 36.31% | 1.69M 38.18% | 1.93M 14.04% | 1.61M 16.49% | 2.80M 74.28% | 4.24M 51.12% | |
book value per share | 0.53 - | 2.46 367.57% | 4.27 73.15% | 1.86 56.42% | 2.78 49.57% | 3.72 33.87% | 4.38 17.53% | 5.25 20.02% | 4.49 14.58% | 2.96 34.03% | 1.05 64.38% | |
capex per share | -0.00 - | -0.00 775.12% | -0.00 59.45% | -0.03 3,135.60% | -0.00 92.93% | -0.00 9.42% | -0.00 79.26% | -0.01 1,644.89% | -0.00 89.55% | -0.00 4.23% | ||
capex to depreciation | -0.01 - | -0.05 746.44% | -0.02 55.56% | -0.49 1,953.12% | -0.12 76.06% | -0.20 68.38% | -0.09 53.92% | -1.67 1,736.84% | -0.16 90.58% | -0.17 10.26% | ||
capex to operating cash flow | -0.00 - | 0.00 234.70% | 0.00 60.89% | 0.02 1,525.10% | 0.00 93.01% | 0.00 209.43% | 0.00 94.97% | 0.06 38,495.80% | 0.00 98.98% | 0.00 15.85% | ||
capex to revenue | -0.00 - | -0.01 3,063.29% | -0.01 60.22% | -8.34 158,432.03% | -0.06 99.24% | -0.01 91.49% | -0.00 83.30% | -0.00 185.43% | -0.00 34.45% | -0.00 39.36% | ||
cash per share | 0.57 - | 2.51 344.00% | 4.34 72.60% | 2.14 50.73% | 2.97 38.87% | 4.50 51.56% | 3.63 19.21% | 3.82 5.04% | 3.29 13.69% | 2.71 17.71% | 1.86 31.34% | |
days of inventory on hand | 119.71 - | 166.77 39.32% | ||||||||||
days payables outstanding | 482.45 - | 1.51K 213.60% | ||||||||||
days sales outstanding | 1.86 - | 22.98 1,134.69% | 44.53 93.81% | 3.99K 8,849.02% | 342.16 91.41% | 43.09 87.41% | 32.80 23.88% | 5.58 83.00% | 18.26 227.40% | 38.82 112.61% | 69.93 80.12% | |
debt to assets | 0.02 - | 0.02 4.93% | 0.01 23.58% | 0.02 41.58% | 0.29 1,299.76% | |||||||
debt to equity | 0.02 - | 0.02 8.42% | 0.02 23.80% | 0.02 49.65% | 0.65 2,588.56% | |||||||
dividend yield | ||||||||||||
earnings yield | -0.01 - | -0.08 504.05% | -0.06 29.93% | -0.23 280.01% | -0.15 32.67% | -0.16 4.22% | -0.15 2.44% | 0.01 107.58% | -0.14 1,317.76% | -0.14 1.39% | -2.95 1,934.96% | |
enterprise value | 269.63M - | 156.37M 42.01% | 400.00M 155.81% | 241.33M 39.67% | 372.53M 54.37% | 451.53M 21.20% | 673.42M 49.14% | 690.95M 2.60% | 607.97M 12.01% | 514.42M 15.39% | 31.62M 93.85% | |
enterprise value over ebitda | -1.14K - | -8.65 99.24% | -15.88 83.54% | -4.13 73.98% | -6.26 51.55% | -5.84 6.83% | -6.03 3.34% | 123.52 2,148.40% | -6.82 105.53% | -5.88 13.89% | -0.26 95.57% | |
ev to operating cash flow | 95.31 - | -8.86 109.30% | -18.62 110.12% | -5.09 72.65% | -6.79 33.40% | -20.25 197.98% | -6.17 69.55% | -125.93 1,942.45% | -10.12 91.96% | -6.53 35.42% | ||
ev to sales | 22.54 - | 49.22 118.39% | 105.18 113.70% | 2.81K 2,567.97% | 408.93 85.43% | 33.52 91.80% | 33.86 1.02% | 5.12 84.90% | 26.40 416.15% | 12.29 53.46% | 1.51 87.72% | |
free cash flow per share | 0.13 - | -0.84 752.38% | -0.87 3.52% | -1.76 101.93% | -1.76 0.24% | -0.62 64.56% | -2.56 310.72% | -0.12 95.19% | -1.19 863.11% | -1.47 23.85% | ||
free cash flow yield | 0.01 - | -0.08 944.76% | -0.05 38.78% | -0.19 266.47% | -0.14 24.28% | -0.05 66.63% | -0.16 231.43% | -0.01 94.88% | -0.10 1,096.38% | -0.14 40.45% | ||
graham net net | 0.27 - | 2.32 764.78% | 4.11 77.60% | 1.68 59.10% | 2.66 58.14% | 2.94 10.40% | 2.57 12.44% | 3.37 30.91% | 2.95 12.32% | 2.36 20.11% | 0.67 71.46% | |
graham number | 1.47 - | 6.85 367.03% | 9.81 43.23% | 9.37 4.47% | 10.80 15.19% | 13.14 21.73% | 15.67 19.20% | 4.58 70.78% | 13.25 189.38% | 10.17 23.20% | 7.21 29.18% | |
income quality | -0.71 - | 0.99 239.27% | 0.87 12.50% | 0.83 4.91% | 0.94 14.03% | 0.30 68.06% | 1.03 240.78% | -0.65 163.54% | 0.68 204.13% | 0.92 35.57% | ||
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | 0.06 - | -143.43 227,407.05% | 352.96 - | -201.15 156.99% | ||||||||
interest debt per share | -0.17 - | 0.01 103.49% | 0.10 - | 0.11 9.91% | 0.07 34.91% | 0.07 7.66% | 0.70 940.64% | |||||
inventory turnover | 3.05 - | 2.19 28.22% | ||||||||||
invested capital | 0.02 - | 0.02 8.42% | 0.02 23.80% | 0.02 49.65% | 0.65 2,588.56% | |||||||
market cap | 281.99M - | 209.03M 25.87% | 415.10M 98.58% | 253.42M 38.95% | 381.92M 50.71% | 466.61M 22.17% | 687.40M 47.32% | 717.36M 4.36% | 617.75M 13.89% | 576.24M 6.72% | 40.23M 93.02% | |
net current asset value | 7.99M - | 48.88M 512.05% | 103.08M 110.89% | 48.34M 53.10% | 84.83M 75.49% | 110.95M 30.78% | 119.41M 7.63% | 172.91M 44.80% | 153.76M 11.08% | 145.45M 5.40% | 47.40M 67.41% | |
net debt to ebitda | 52.14 - | 2.91 94.41% | 0.60 79.43% | 0.21 65.46% | 0.16 23.78% | 0.19 23.49% | 0.13 35.74% | -4.72 3,869.56% | 0.11 102.33% | 0.71 543.32% | 0.07 89.97% | |
net income per share | -0.18 - | -0.85 366.49% | -1.00 18.49% | -2.10 109.39% | -1.86 11.29% | -2.06 10.70% | -2.49 20.90% | 0.18 107.12% | -1.74 1,080.32% | -1.55 10.59% | -2.19 40.78% | |
operating cash flow per share | 0.13 - | -0.84 749.68% | -0.87 3.67% | -1.74 99.10% | -1.76 1.16% | -0.62 64.64% | -2.56 311.99% | -0.12 95.48% | -1.18 923.71% | -1.47 23.86% | ||
payables turnover | 0.76 - | 0.24 68.11% | ||||||||||
receivables turnover | 196.13 - | 15.88 91.90% | 8.20 48.40% | 0.09 98.88% | 1.07 1,064.74% | 8.47 694.10% | 11.13 31.37% | 65.45 488.12% | 19.99 69.46% | 9.40 52.97% | 5.22 44.48% | |
research and ddevelopement to revenue | 0.73 - | 4.74 553.35% | 5.58 17.65% | 572.71 10,163.48% | 53.26 90.70% | 5.61 89.47% | 5.72 2.07% | 0.80 86.05% | 3.59 349.81% | 2.19 38.89% | 5.18 135.81% | |
return on tangible assets | -0.22 - | -0.32 44.76% | -0.22 29.82% | -0.90 303.08% | -0.60 33.23% | -0.39 35.27% | -0.46 17.73% | 0.03 106.79% | -0.36 1,250.97% | -0.46 28.22% | -0.94 105.75% | |
revenue per share | 0.55 - | 0.15 72.34% | 0.15 1.94% | 0.00 97.96% | 0.03 826.09% | 0.38 1,185.30% | 0.47 24.19% | 2.85 511.32% | 0.45 84.06% | 0.78 71.86% | 0.39 50.38% | |
roe | -0.34 - | -0.34 0.23% | -0.24 31.57% | -1.13 380.43% | -0.67 40.69% | -0.55 17.31% | -0.57 2.86% | 0.03 105.93% | -0.39 1,247.67% | -0.53 35.53% | -2.08 295.19% | |
roic | -0.02 - | -0.35 1,592.71% | -0.24 31.77% | -1.14 383.91% | -0.68 40.19% | -0.58 15.67% | -0.57 1.51% | 0.02 103.98% | -0.38 1,773.22% | -0.52 37.27% | -1.21 133.42% | |
sales general and administrative to revenue | 0.29 - | 1.95 562.02% | 2.04 5.02% | 107.36 5,154.72% | 13.03 87.86% | 1.14 91.27% | 0.89 21.55% | 0.16 81.96% | 1.28 693.23% | 0.72 43.41% | ||
shareholders equity per share | 0.53 - | 2.46 367.57% | 4.27 73.15% | 1.86 56.42% | 2.78 49.57% | 3.72 33.87% | 4.38 17.53% | 5.25 20.02% | 4.49 14.58% | 2.96 34.03% | 1.05 64.38% | |
stock based compensation to revenue | 0.01 - | 0.43 4,097.51% | 0.66 53.19% | 32.56 4,825.16% | 6.36 80.47% | 0.70 88.93% | 0.63 10.19% | 0.11 82.62% | 0.90 721.87% | 0.42 53.07% | ||
tangible asset value | 11.51M - | 51.66M 348.81% | 105.04M 103.33% | 50.73M 51.71% | 86.78M 71.08% | 133.63M 53.99% | 186.71M 39.72% | 249.00M 33.36% | 227.52M 8.63% | 158.78M 30.21% | 57.09M 64.05% | |
tangible book value per share | 0.53 - | 2.46 367.57% | 4.27 73.15% | 1.86 56.42% | 2.78 49.57% | 3.72 33.87% | 4.38 17.53% | 5.25 20.02% | 4.49 14.58% | 2.96 34.03% | 1.05 64.38% | |
working capital | 9.13M - | 49.75M 445.23% | 103.67M 108.37% | 49.91M 51.85% | 86.55M 73.41% | 127.69M 47.53% | 122.76M 3.86% | 176.58M 43.84% | 155.67M 11.84% | 145.45M 6.57% | 90.57M 37.73% |
All numbers in USD (except ratios and percentages)